Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after <scp>anti‐TNF</scp> and <scp>anti‐</scp>interleukin‐17 failures
Raffaele Dante Caposiena, Chiara Pensa, Sara Lambiase, Eleonora Candi, Luca Bianchi
Abstract
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Topics & Concepts
MedicineHidradenitis suppurativaDermatologyTumor necrosis factor alphaImmunologyInternal medicineDiseaseHidradenitis Suppurativa and TreatmentsColorectal and Anal CarcinomasChemotherapy-related skin toxicity